Foci Pharmaceutical: Announcement of Resolutions of the Third Meeting of the Eighth Board of Directors
Foci Pharmaceuticals: 002644 Foci Pharmaceuticals Investor Relations Management Information 20240920
Foci Pharmaceutical: Continued supervision of Hualong Securities Co., Ltd. on Gansu State-owned Assets Investment Group Co., Ltd.\'s offer to acquire Lanzhou Foci Pharmaceutical Co., Ltd. in the second quarter of 2024
Foci Pharmaceuticals: 002644 Foci Pharmaceuticals Investor Relations Management Information 20240828
Foci Pharmaceuticals: Semi-Annual Report Board Resolution Announcement
Foci Pharmaceuticals: Announcement on increasing the forecast for daily related transactions in 2024
Lanzhou Foci Pharmaceutical: Announcement of the resolution of the first meeting of the eighth board of supervisors.
Lanzhou Foci Pharmaceutical: Announcement of Resolutions Passed at the First Meeting of the Eighth Board of Directors.
Lanzhou Foci Pharmaceutical: Statement and Commitment of Independent Director Nominee (Hu Huayun)
Lanzhou Foci Pharmaceutical: Statement and Commitment of Independent Director Candidate (Hu Huayun)
Lanzhou Foci Pharmaceutical: Statement and Commitment of Independent Director Nominee (Li Zhigang)
Lanzhou Foci Pharmaceutical: Announcement of Resolutions of the 28th Meeting of the Seventh Board of Directors.
Lanzhou Foci Pharmaceutical: Announcement of Resolution of the 22nd Meeting of the 7th Supervisory Committee.
Lanzhou Foci Pharmaceutical: Statement and Commitment of Independent Director Candidate (Li Zhigang)
Lanzhou Foci Pharmaceutical: Statement and Commitment of Independent Director Nominee (Jia Hongwen)
Lanzhou Foci Pharmaceutical: Statement and commitment of independent director candidate (Jia Hongwen)
Lanzhou Foci Pharmaceutical: Announcement of Resolutions of the 27th Meeting of the 7th Board of Directors
Foci Pharmaceuticals: Hualong Securities's 2023 Continued Supervision Opinions on Gansu State-owned Assets Investment Group Co., Ltd.'s bid to acquire Lanzhou Foci Pharmaceutical Co., Ltd.
Foci Pharmaceutical: Continued supervision of Hualong Securities on Gansu State-owned Assets Investment Group Co., Ltd.'s offer to acquire Lanzhou Foci Pharmaceutical Co., Ltd. in the first quarter of 2024
Foci Pharmaceuticals: 002644 Foci Pharmaceuticals Investor Relations Management Information 20240418
No Data
No Data